John Orloff

Dr. John J.
Orloff, MD, is an Independent Director at Zenas BioPharma, Inc. and a Venture Partner at Agent Capital LLC.
He is on the Board of Directors at Zenas BioPharma, Inc. and Zenas BioPharma (USA) LLC.
Dr. Orloff was previously employed as a Non-Executive Director by BenevolentAI Ltd., an Independent Non-Executive Director by BenevolentAI SA, an Executive VP, Head-Research & Development by Alexion Pharmaceuticals, Inc., an Executive Vice President & Head-Research by Aegerion Pharmaceuticals, Inc., a Chief Scientific Officer, EVP, Global Head-R&D by Baxalta, Inc., a Vice President, Global Head-Research & Development by Baxter BioScience Corp., a Senior Director by Merck Research Laboratories Massachusetts LLC, and a Chief Medical Officer & Senior Vice President by Novartis Pharma AG.
He also served on the board at Novelion Therapeutics, Inc. He received his undergraduate degree from Dartmouth College and a doctorate degree from the University of Vermont College of Medicine.